Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy

American Journal of Ophthalmology

Volumn 135, Issue 3, 2003, Pages 343-350

  Moshfeghi, Darius M ^a   Kaiser, Peter K ^a   Grossniklaus, Hans E ^b   Sternberg Jr , Paul ^b   Sears, Jonathan E ^a   Johnson, Mark W ^c   Ratliff, Norman ^a   Branco, Andre ^d   Blumenkranz, Mark S ^d   Lewis, Hilel ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; CITRIC ACID; EOSIN; FIBRIN; HEMATOXYLIN; LEAD; TOLONIUM CHLORIDE; URANYL ACETATE;

ADULT; AGED; ARTICLE; BLOOD VESSEL OCCLUSION; CHOROIDITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ERYTHROCYTE; EXTRAVASATION; EYE SURGERY; FEMALE; HISTOPATHOLOGY; HISTOPLASMOSIS; HUMAN; IDIOPATHIC DISEASE; INFLAMMATORY CELL; MALE; MEMBRANE; MICROSCOPY; MYOPIA; PATHOLOGY; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HEMORRHAGE; RETINA MACULA LUTEA; RETROSPECTIVE STUDY; STAINING; SUBRETINAL NEOVASCULARIZATION; TISSUE SECTION; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ADULT; AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULA LUTEA; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 0037373678     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)01936-0     Document Type: Article

References (23)

1. Miller J.W., Schmidt-Erfurth U., Sickenberg M., et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration results of a single treatment in a phase 1 and 2 study . Arch Ophthalmol. 117:1999;1161-1173.
2. Schmidt-Erfurth U., Miller J.W., Sickenberg M., et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration results of retreatments in a phase 1 and 2 study . Arch Ophthalmol. 117:1999;1177-1187.
3. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of two randomized clinical trials - TAP Report 1. Arch Ophthalmol. 117:1999;1329-1345.
4. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two year results of 2 randomized clinical trials - TAP Report 2. Arch Ophthalmol. 119:2001;198-207.
5. Sickenberg M., Schmidt-Erfurth U., Miller J.W., et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol. 118:2000;327-336.
6. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial - VIP report no. 1. Ophthalmology 2001;108:841-852.
7. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration. two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001;131:541-560.
8. Schmidt-Erfurth U., Hasan T. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol. 45:2000;195-214.
9. Miller J.W., Walsh A.W., Kramer M., et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol. 113:1995;810-818.
10. Kramer M., Miller J.W., Michaud N., et al. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. Ophthalmology. 103:1996;427-438.
11. Husain D., Miller J.W., Michaud N., Connolly E., Flotte T.J., Gragoudas E.S. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol. 114:1996;978-985.
12. Husain D., Kramer M., Kenny A.G., et al. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci. 40:1999;2322-2331.
13. Reinke M.H., Canakis C., Husain D., et al. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology. 106:1999;1915-1923.
14. Grossniklaus H.E., Hutchinson A.K., Capone A.C. Sr, Woolfson J., Lambert H.M. Clinicopathologic features of surgically excised choroidal neovascular membranes. Ophthalmology. 101:1994;1099-1111.
15. Grossniklaus H.E., Gass J.D.M. Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. Am J Ophthalmol. 126:1998;59-69.
16. Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Arch Ophthalmol. 104:1986;694-701.
17. Schmidt-Erfurth U., Miller J., Sickenberg M., et al. Photodynamic therapy of subfoveal choroidal neovascularization clinical and angiographic examples . Graefes Arch Clin Exp Ophthalmol. 236:1998;365-374.
18. Ghazi N.G., Jabbour N.M., de la Cruz Z.C., Green W.R. Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy. Retina. 21:2001;478-486.
19. Schnurrbusch U.E.K., Welt K., Horn L.-C., Wiedemann P., Wolf S. Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy. Br J Ophthlamol. 85:2001;1086-1091.
20. Royster A.J., Nanda S.K., Hatchell D.L., Tiedemann J.S., Dutton J.J., Hatchell M.C. Photochemical initiation of thrombosis. Fluorescein angiographic, histologic, and ultrastructural alterations in the choroid, retinal pigment epithelium, and retina. Arch Ophthalmol. 106:1988;1608-1614.
21. Flower R.W. Experimental studies of indocyanine green dye-enhanced photocoagulation of choroidal neovascularization feeder vessels. Am J Ophthalmol. 129:2000;510-512.
22. Flower R.W., von Kerczek C., Zhu L., Ernest A., Eggleton C., Topoleski L.D.T. Theoretical investigation of the role of choriocapillaris blood flow in treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration. Am J Ophthalmol. 132:2001;85-93.
23. Schmidt-Erfurth U., Michels S., Barbazetto I., Laqua H. Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci. 43:2002;830-841.